Key Highlights:
- Philips has launched Oxygenate 5 in India, a stationary oxygen concentrator designed to support long-term oxygen therapy at home for people with chronic respiratory conditions and severe hypoxaemia.
- Delivering continuous oxygen flow from 0.5–5 L/min, Oxygenate 5 features quieter operation below 40 dB, a digital flow display and nine levels of filtration to simplify everyday therapy and maintenance.
- With user-replaceable filters, a 10,000-hour sieve warranty and a three-year limited warranty, the device aims to support patients, caregivers and clinicians. It will be showcased at NAPCON 2026 in Kolkata.
Implications:
Philips’ Oxygenate 5 strengthens its home respiratory care portfolio in India, targeting growing demand for long-term oxygen therapy as care shifts beyond hospitals. Quieter operation, simplified maintenance and extended warranty coverage could appeal to patients, caregivers and durable medical equipment providers. Pricing, distribution reach and service support will be key to adoption.
Source: Pharmabiz
